News

     

Litigating over royalty payments between two pharmaceutical companies in Switzerland

By Gavin Lunning
Back to News

Author:

Gavin Lunning

The firm is instructed to act on behalf of two pharmaceutical companies in relation to a dispute with a global healthcare company in respect to a potential breach of a pharmaceutical licence agreement and a dispute over royalty payments. The case involves a challenge to third party expert determination in respect to the calculation of royalty payments in respect to the licensing of pharmaceutical products.

Latest news

All news